Implementation of an Evidence-Based Tobacco Use Treatment Intervention in the Context of Lung Cancer Screening

2018 ◽  
Author(s):  
Jamie S. Ostroff ◽  
Donna Shelley
Keyword(s):  
Lung Cancer ◽  
Cancer Screening ◽  
Tobacco Use ◽  
Lung Cancer Screening ◽  
Helical Computed Tomography ◽  
Evidence Based ◽  
Treatment Interventions ◽  
Smoking Cessation Treatment ◽  
Tobacco Treatment

Lung cancer screening using low-dose helical computed tomography is now recommended for early detection of lung cancer. This case study provides an overview of a study that is testing the effectiveness of tobacco treatment interventions for high-risk smokers seeking lung cancer screening and examining factors that may influence implementation process and sustainability for delivering effective models of smoking cessation treatment in lung cancer screening settings. The focus of the case study is a description of how and why two implementation frameworks were applied to evaluate the implementation outcomes and additional multilevel factors (i.e., organization and intervention characteristics) that may influence effective implementation of evidence-based tobacco use treatment interventions in the context of lung cancer screening. Ultimately, implementation of high-quality tobacco treatment in lung cancer screening settings is likely to further reduce tobacco-related cancer morbidity and mortality.

Lung Cancer Screening, Cancer Treatment, and Addressing the Continuum of Health Risks Caused by Tobacco

2016 ◽  
pp. 223-229 ◽  
Author(s):  
Graham W. Warren ◽  
Jamie S. Ostroff ◽  
John R. Goffin
Keyword(s):  
Lung Cancer ◽  
Cancer Screening ◽  
Cancer Treatment ◽  
Tobacco Use ◽  
Health Risks ◽  
Lung Cancer Screening ◽  
Adverse Outcomes ◽  
Evidence Based ◽  
Patients With Cancer ◽  
Preventable Risk Factor

Tobacco use is the largest preventable risk factor for the development of several cancers, and continued tobacco use by patients with cancer and survivors of cancer causes adverse outcomes. Worldwide tobacco control efforts have reduced tobacco use and improved health outcomes in many countries, but several countries continue to suffer from increased tobacco use and associated adverse health effects. Continued tobacco use by patients undergoing cancer screening or treatment results in continued risk for cancer-related and noncancer-related health conditions. Although integrating tobacco assessment and cessation support into lung cancer screening and cancer care is well justified and feasible, most patients with cancer unfortunately do not receive evidence-based tobacco cessation support. Combining evidence-based methods of treating tobacco addiction, such as behavioral counseling and pharmacotherapy, with practical clinical considerations in the setting of lung cancer screening and cancer treatment should result in substantial improvements in access to evidence-based care and resultant improvements in health risks and cancer treatment outcomes.

Tobacco Treatment Specialist Training for Lung Cancer Screening Providers

2021 ◽  
Author(s):  
Kelly L. Roughgarden ◽  
Benjamin A. Toll ◽  
Nichole T. Tanner ◽  
Cassie C. Frazier ◽  
Gerard A. Silvestri ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Screening ◽  
Lung Cancer Screening ◽  
Specialist Training ◽  
Tobacco Treatment ◽  
Treatment Specialist

scholarly journals Effective Dose Estimations for Helical Computed Tomography in Lung Cancer Screening

2001 ◽  
Vol 57 (8) ◽  
pp. 939-946 ◽  
Author(s):  
HIDEAKI OKAMOTO ◽  
MASAYOSHI MIYAZAKI ◽  
AKITOSHI YONEDA ◽  
KEIICHI SUZUKI ◽  
KOUKI UEDA ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Lung Cancer ◽  
Cancer Screening ◽  
Effective Dose ◽  
Lung Cancer Screening ◽  
Helical Computed Tomography

scholarly journals A Proactive Telephone-Delivered Risk Communication Intervention for Smokers Participating in Lung Cancer Screening: A Pilot Feasibility Trial

2017 ◽  
Vol 13 (3) ◽  
pp. 137-144 ◽  
Author(s):  
Steven B. Zeliadt ◽  
Preston A. Greene ◽  
Paul Krebs ◽  
Deborah E. Klein ◽  
Laura C. Feemster ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Screening ◽  
Usual Care ◽  
Usual Care Group ◽  
Intervention Group ◽  
Lung Cancer Screening ◽  
Feasibility Trial ◽  
Care Group ◽  
Telephone Counselling ◽  
Tobacco Treatment

Introduction: Many barriers exist to integrating smoking cessation into delivery of lung cancer screening including limited provider time and patient misconceptions.Aims: To demonstrate that proactive outreach from a telephone counsellor outside of the patient's usual care team is feasible and acceptable to patients.Methods: Smokers undergoing lung cancer screening were approached for a telephone counselling study. Patients agreeing to participate in the intervention (n = 27) received two telephone counselling sessions. A 30-day follow-up evaluation was conducted, which also included screening participants receiving usual care (n = 56).Results/Findings: Most (89%) intervention participants reported being satisfied with the proactive calls, and 81% reported the sessions were helpful. Use of behavioural cessation support programs in the intervention group was four times higher (44%) compared to the usual care group (11%); Relative Risk (RR) = 4.1; 95% CI: 1.7 to 9.9), and seven-day abstinence in the intervention group was double (19%) compared to the usual care group (7%); RR = 2.6; 95% CI: 0.8 to 8.9).Conclusions: This practical telephone-based approach, which included risk messages clarifying continued risks of smoking in the context of screening results, suggests such messaging can boost utilisation of evidence-based tobacco treatment, self-efficacy, and potentially increase the likelihood of successful quitting.

Lung Cancer Screening: Promise and Pitfalls

2012 ◽  
pp. 450-457
Author(s):  
Christine D. Berg ◽  
Denise R. Aberle ◽  
Douglas E. Wood
Keyword(s):  
Lung Cancer ◽  
Cancer Screening ◽  
Cancer Mortality ◽  
Lung Cancer Screening ◽  
Lung Cancer Mortality ◽  
Medical Community ◽  
Helical Computed Tomography ◽  
Screening Guidelines ◽  
Screening Programs ◽  
National Lung Screening Trial

OVERVIEW: The results of the National Lung Screening Trial (NLST) have provided the medical community and American public with considerable optimism about the potential to reduce lung cancer mortality with imaging-based screening. Designed as a randomized trial, the NLST has provided the first evidence of screening benefit by showing a 20% reduction in lung cancer mortality and a 6.7% reduction in all-cause mortality with low dose helical computed tomography (LDCT) screening relative to chest X-ray. The major harms of LDCT screening include the potential for radiation-induced carcinogenesis; high false-positivity rates in individuals without lung cancer, and overdiagnosis. Following the results of the NLST, the National Comprehensive Cancer Network (NCCN) published the first of multiple lung cancer screening guidelines under development by major medical organizations. These recommendations amalgamated screening cohorts, practices, interpretations, and diagnostic follow-up based on the NLST and other published studies to provide guidance for the implementation of LDCT screening. There are major areas of opportunity to optimize implementation. These include standardizing practices in the screening setting, optimizing risk profiles for screening and for managing diagnostic evaluation in individuals with indeterminate nodules, developing interdisciplinary screening programs in conjunction with smoking cessation, and approaching all stakeholders systematically to ensure the broadest education and dissemination of screening benefits relative to risks. The incorporation of validated biomarkers of risk and preclinical lung cancer can substantially enhance the effectiveness screening programs.

Helical computed tomography for lung cancer screening

2003 ◽  
Vol 179 (3) ◽  
pp. 125-126 ◽  
Author(s):  
Mark Elwood ◽  
Donald A Campbell ◽  
Margaret P De Campo
Keyword(s):  
Computed Tomography ◽  
Lung Cancer ◽  
Cancer Screening ◽  
Lung Cancer Screening ◽  
Helical Computed Tomography

scholarly journals Lung Cancer Screening With Helical Computed Tomography in Older Adult Smokers

JAMA ◽  
2003 ◽  
Vol 289 (3) ◽  
pp. 313 ◽  
Author(s):  
Parthiv J. Mahadevia ◽  
Lee A. Fleisher ◽  
Kevin D. Frick ◽  
John Eng ◽  
Steven N. Goodman ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Lung Cancer ◽  
Cancer Screening ◽  
Older Adult ◽  
Lung Cancer Screening ◽  
Helical Computed Tomography
Sign in / Sign up

Export Citation Format

Share Document